Opioid Addiction
Once-weekly subcutaneous buprenorphine injections block the euphoric effects of opioids and suppress opioid withdrawal in patients with opioid use disorder.
Chronic Pain
No studies comparing opioid use vs. non-opioid use have evaluated quality of life, opioid abuse or addiction outcomes.
Opioid Addiction
Marketing of opioids to physicians is associated with increased mortality from opioid overdoses.
Opioid Addiction
Lofexidine may help patients with opioid withdrawal symptoms or difficulty with opioid discontinuation.
Opioid Addiction
Availability of prescription opioids in the household may increase the risk for opioid initiation in coresidents.
Opioid Addiction
The treatment combines buprenorphine, a partial-opioid agonist, with naloxone, an opioid antagonist.
Opioid Addiction
The quantity of opioids prescribed after surgery is associated with patient-reported opioid consumption.
General Pain
Rates of opioid administration were found to be high in opioid-naive inpatients.
Opioid Addiction
Co-prescribing naloxone with opioids may reduce opioid overdoses while playing a pivotal role in combating the nation's opioid addiction epidemic.
Opioid Addiction
Prescription opioid duration — not dosage — following surgery may be associated with a greater risk for opioid misuse in patients with no prior history of opioid use.
